Cargando…

A radiobiological study of the schemes with a low number of fractions in high-dose-rate brachytherapy as monotherapy for prostate cancer

PURPOSE: Schemes with high doses per fraction and small number of fractions are commonly used in high-dose-rate brachytherapy (HDR-BT) for prostate cancer. Our aim was to analyze the differences between published clinical results and the predictions of radiobiological models for absorbed dose requir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guirado, Damián, Ruiz-Arrebola, Samuel, Tornero-López, Ana M., de la Vega, Jose M., Prada, Pedro J., Lallena, Antonio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207227/ https://www.ncbi.nlm.nih.gov/pubmed/32395145 http://dx.doi.org/10.5114/jcb.2020.94492

Ejemplares similares

High-dose-rate brachytherapy delivered in two fractions as monotherapy for low-risk prostate cancer
por: Cendales, Ricardo, et al.
Publicado: (2015)

High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysis
por: Anderson, Eric M., et al.
Publicado: (2021)

Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study
por: Waldron, Timothy J., et al.
Publicado: (2021)

Qualitative Dosimetric and Radiobiological Evaluation of High – Dose – Rate Interstitial brachytherapy Implants
por: Kehwar, Than S., et al.
Publicado: (2008)

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective
por: Yoshioka, Yasuo, et al.
Publicado: (2014)

Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
por: Contreras, Jessika A., et al.
Publicado: (2015)

Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
por: Galego, Pedro, et al.
Publicado: (2015)

Prostate cancer boost using high-dose-rate brachytherapy: early toxicity analysis of 3 different fractionation schemes
por: Hijazi, Hussam, et al.
Publicado: (2013)

Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants
por: Mavroidis, Panayiotis, et al.
Publicado: (2010)

Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses
por: Miguel, David, et al.
Publicado: (2018)

Intraoperative Neurovascular Bundle Preservation with Hyaluronic Acid during Radical Brachytherapy for Localized Prostate Cancer: Technique and MicroMosfet In Vivo Dosimetry
por: Prada, Pedro J., et al.
Publicado: (2022)

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
por: Xue, Hui, et al.
Publicado: (2021)

Dosimetric and radiobiological evaluation of treatment plan for cervical cancer high-dose-rate intracavitary brachytherapy
por: Kaur, Gurpreet, et al.
Publicado: (2022)

Evaluation of the overdiagnosis in breast screening programmes using a Monte Carlo simulation tool: a study of the influence of the parameters defining the programme configuration
por: Forastero, Cristina, et al.
Publicado: (2019)

Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
por: Barnes, Justin M., et al.
Publicado: (2019)

IMRT and brachytherapy comparison in gynaecological cancer treatment: thinking over dosimetry and radiobiology
por: Pinzi, Valentina, et al.
Publicado: (2019)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

Hypofractionation trials and radiobiology of prostate cancer
por: Gulliford, Sarah, et al.
Publicado: (2017)

Treatment Planning Methods in High Dose Rate Interstitial Brachytherapy of Carcinoma Cervix: A Dosimetric and Radiobiological Analysis
por: Anbumani, Surega, et al.
Publicado: (2014)

Late toxicity and five year outcomes after high-dose-rate brachytherapy as a monotherapy for localized prostate cancer
por: Ghadjar, Pirus, et al.
Publicado: (2014)

Radiobiological and Treatment-Related Aspects of Spatially Fractionated Radiotherapy
por: Moghaddasi, Leyla, et al.
Publicado: (2022)

Hypofractionation in Prostate Cancer: Radiobiological Basis and Clinical Appliance
por: Mangoni, M., et al.
Publicado: (2014)

A Report on the Clinical Outcome after High-Dose Rate (HDR) Brachytherapy as Monotherapy in Early Prostate Cancer
por: Potharaju, Mahadev, et al.
Publicado: (2015)

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023)

Introduction to Radiobiology
por: Tubiona, M
Publicado: (1990)

Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy
por: Huang, Bao-Tian, et al.
Publicado: (2015)

Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
por: Shibamoto, Yuta, et al.
Publicado: (2016)

Radiobiological Meta-Analysis of the Response of Prostate Cancer to Different Fractionations: Evaluation of the Linear–Quadratic Response at Large Doses and the Effect of Risk and ADT
por: Pardo-Montero, Juan, et al.
Publicado: (2023)

High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience
por: Soatti, Carlo Pietro, et al.
Publicado: (2020)

Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer
por: Wen, Aiping, et al.
Publicado: (2022)

High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients
por: Tselis, Nikolaos, et al.
Publicado: (2013)

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center
por: Johansson, Bengt, et al.
Publicado: (2021)

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes
por: le Guyader, Maud, et al.
Publicado: (2021)

Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: preliminary results
por: Latorre, Javier Anchuelo, et al.
Publicado: (2018)

Radiobiology for heavy particles
por: Bianchi, M
Publicado: (1982)

Basic clinical radiobiology
por: Williams, M. V.
Publicado: (1994)

Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020)

Modelling the radiobiological effect of intraoperative X-ray brachytherapy for breast cancer using an air-filled spherical applicator
por: Armoogum, Kris, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bp14r1sulr8o327do8eimmv8nh